Stock data
Xenetic Biosciences, Inc. (XBIO)
Xenetic Biosciences, Inc. (XBIO) reported revenue of US$2.98M and net income of -US$2.68M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$2.98M | — | -US$2.83M | -US$2.68M | — |
| 2024 | US$2.50M | — | -US$4.20M | -US$3.96M | — |
| 2023 | US$2.54M | — | -US$4.52M | -US$4.13M | — |
| 2022 | US$1.71M | — | -US$6.72M | -US$6.55M | — |
| 2021 | US$1.16M | — | -US$5.75M | -US$5.65M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$0.66M | -US$0.93M | — |
| 2026-03-31 | US$0.81M | -US$0.46M | — |
| 2025-12-31 | US$0.77M | -US$0.58M | — |
| 2025-09-30 | US$1.03M | -US$0.51M | — |
| 2025-06-30 | US$0.59M | -US$0.69M | — |
| 2025-03-31 | US$0.59M | -US$0.90M | — |
| 2024-12-31 | US$0.65M | -US$1.05M | — |
| 2024-09-30 | US$0.61M | -US$0.44M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.